Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
35
CCEP Quote, Financials, Valuation and Earnings
Last price:
$75.19
Seasonality move
:
7.83%
Day range:
$74.23 - $76.00
52-week range:
$64.25 - $82.32
Dividend yield:
2.78%
P/E ratio:
19.94x
P/S ratio:
1.68x
P/B ratio:
3.79x
Volume:
2.5M
Avg. volume:
1.6M
1-year change:
16.57%
Market cap:
$34.6B
Revenue:
$19.8B
EPS (TTM):
$3.77
Analysts' Opinion
-
Consensus RatingCoca-Cola Europacific Partners PLC has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $80.61, Coca-Cola Europacific Partners PLC has an estimated upside of 9.64% from its current price of $75.15.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $61.90 representing 100% downside risk from its current price of $75.15.
Fair Value
-
According to the consensus of 11 analysts, Coca-Cola Europacific Partners PLC has 9.64% upside to fair value with a price target of $80.61 per share.
CCEP vs. S&P 500
-
Over the past 5 trading days, Coca-Cola Europacific Partners PLC has underperformed the S&P 500 by -2.77% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Coca-Cola Europacific Partners PLC does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Coca-Cola Europacific Partners PLC has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Coca-Cola Europacific Partners PLC reported revenues of --.
Earnings Growth
-
Coca-Cola Europacific Partners PLC earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Coca-Cola Europacific Partners PLC reported earnings per share of --.
Enterprise value:
45.4B
EV / Invested capital:
--
Price / LTM sales:
1.68x
EV / EBIT:
17.99x
EV / Revenue:
2.20x
PEG ratio (5yr expected):
1.82x
EV / Free cash flow:
21.02x
Price / Operating cash flow:
14.37x
Enterprise value / EBITDA:
13.15x
Gross Profit (TTM):
$7.5B
Return On Assets:
5.25%
Net Income Margin (TTM):
8.42%
Return On Equity:
19.35%
Return On Invested Capital:
8.26%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2021-05-31 | 2022-05-31 | 2023-05-31 | 2022-05-31 | 2023-05-31 | |
| Income Statement | ||||||
| Revenue | $3.2B | $1.2M | $1.6M | $330K | $510K | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $4.3B | $7.2B | $7.3B | $8.1B | $8.1B | |
| Total Assets | $21.4B | $34.7B | $31.7B | $32.4B | $34.4B | |
| Current Liabilities | $4.5B | $7.9B | $7.7B | $9.5B | $9.5B | |
| Total Liabilities | $14.9B | $26.6B | $23.6B | $23.9B | $24.8B | |
| Total Equity | $6.6B | $8.1B | $8.1B | $8.4B | $9.7B | |
| Total Debt | $7.6B | $15.4B | $12.5B | $12.1B | $12.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2017-12-31 | 2018-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | $506.1M | $481.4M | |
| Cash From Investing | -- | -- | -- | -$214.1M | -$318.9M | |
| Cash From Financing | -- | -- | -- | -$420.6M | -$368.1M | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
CCEP
Sector
Market Cap
$34.6B
$348.1M
Price % of 52-Week High
91.29%
73.74%
Dividend Yield
2.78%
0%
Shareholder Yield
--
2.64%
1-Year Price Total Return
16.57%
-12.75%
Beta (5-Year)
0.912
0.504
Dividend yield:
2.78%
Annualized payout:
$2.01
Payout ratio:
33.07%
Growth streak:
3 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$77.15
200-day SMA
Buy
Level
$74.95
Bollinger Bands (100)
Sell
Level
75.67 - 79.81
Chaikin Money Flow
Buy
Level
448.6M
20-day SMA
Sell
Level
$77.63
Relative Strength Index (RSI14)
Sell
Level
38.86
ADX Line
Sell
Level
11.84
Williams %R
Buy
Level
-83.8028
50-day SMA
Sell
Level
$77.34
MACD (12, 26)
Sell
Level
-0.38
25-day Aroon Oscillator
Sell
Level
-36
On Balance Volume
Neutral
Level
636.2M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.0221)
Sell
CA Score
(Annual)
Level (-0.9453)
Buy
Beneish M-Score
(Annual)
Level (-2.6091)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (0.2965)
Buy
Piotroski F Score
(Annual)
Level (9)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
CCEP is the second-largest bottling partner in the Coca-Cola system by volume, behind Coca-Cola Femsa, and primarily operates in developed Europe (80% of 2023 revenue and EBIT) and Australasia (20%).In 2023, CCEP sold 3.3 billion unit cases of beverages, which we estimate equates to roughly 9% of the global Coke system volume. Coke’s largest bottler, Coca-Cola Femsa sold 4 billion unit cases (12%), and the third-largest, Coca-Cola HBC, serving Eastern Europe and North Africa, sold 2.8 billion unit cases (8%).TCCC owns 19% of the equity of CCEP, Olive Partners, a holding company of bottling operations, owns a further 36%, and the remaining 45% is free float.
Stock Forecast FAQ
In the current month, CCEP has received 8 Buy ratings 3 Hold ratings, and 0 Sell ratings. The CCEP average analyst price target in the past 3 months is $80.61.
-
Where Will Coca-Cola Europacific Partners PLC Stock Be In 1 Year?
According to analysts, the consensus estimate is that Coca-Cola Europacific Partners PLC share price will rise to $80.61 per share over the next 12 months.
-
What Do Analysts Say About Coca-Cola Europacific Partners PLC?
Analysts are divided on their view about Coca-Cola Europacific Partners PLC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Coca-Cola Europacific Partners PLC is a Sell and believe this share price will drop from its current level to $61.90.
-
What Is Coca-Cola Europacific Partners PLC's Price Target?
The price target for Coca-Cola Europacific Partners PLC over the next 1-year time period is forecast to be $80.61 according to 11 Wall Street analysts, 8 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is CCEP A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Coca-Cola Europacific Partners PLC is a Buy. 8 of 11 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CCEP?
You can purchase shares of Coca-Cola Europacific Partners PLC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Coca-Cola Europacific Partners PLC shares.
-
What Is The Coca-Cola Europacific Partners PLC Share Price Today?
Coca-Cola Europacific Partners PLC was last trading at $75.19 per share. This represents the most recent stock quote for Coca-Cola Europacific Partners PLC. Yesterday, Coca-Cola Europacific Partners PLC closed at $75.15 per share.
-
How To Buy Coca-Cola Europacific Partners PLC Stock Online?
In order to purchase Coca-Cola Europacific Partners PLC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
